Use of Dietary Supplements and Perceived Knowledge among Adults Living with Fibromyalgia in Norway: A Cross-Sectional Study.
Norway
dietary supplements
fibromyalgia syndrome
health claims
informed health choices
musculoskeletal disorders
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
21 Dec 2021
21 Dec 2021
Historique:
received:
15
11
2021
revised:
15
12
2021
accepted:
17
12
2021
entrez:
11
1
2022
pubmed:
12
1
2022
medline:
27
1
2022
Statut:
epublish
Résumé
Fibromyalgia syndrome (FMS) is a complex medical condition characterized by widespread musculoskeletal pain. To date, no gold standard treatment has been developed, and persons with FMS often seek alternative methods to control their symptoms, such as dietary supplements (DS). This study aimed to describe the use of DS in persons living with FMS and examine the associations between the use of DS and its potential predictors. We recruited a convenience sample of 504 participants (≥18 years) living with FMS. The main outcome variables included estimated expenditure on DS in the last 12 months in Norwegian kroner (NOK) and the differences between the groups of users and non-users of DS. Of the 504 participants, 430 reported having used DS, and the mean amount of money spent in the previous year was determined to be NOK 2300. The most common DS reported were vitamin D, magnesium, and omega-3 fatty acids. The predictors of being a DS user were high education, high self-reported knowledge of DS but low overall knowledge of health claims. Users of DS marketed for muscles/joints appear to spend more money on DS. The increasing availability of DS and aggressive advertising in the media through health claims stipulate the need for interventions that lead to informed decisions about DS.
Identifiants
pubmed: 35010882
pii: nu14010005
doi: 10.3390/nu14010005
pmc: PMC8746737
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
J Rheumatol. 2014 Jul;41(7):1398-404
pubmed: 24931954
Arthritis Rheum. 2007 Feb 15;57(1):71-6
pubmed: 17266066
Tidsskr Nor Laegeforen. 2010 Dec 2;130(23):2365-8
pubmed: 21139663
Evid Based Complement Alternat Med. 2017;2017:6751856
pubmed: 28811828
Br J Nutr. 2015 Jun 28;113(12):1993-2000
pubmed: 25940747
Tidsskr Nor Laegeforen. 2002 May 20;122(13):1300-4
pubmed: 12098926
Pharmacoeconomics. 2014 May;32(5):457-66
pubmed: 24504852
Pharm Pract (Granada). 2007 Oct;5(4):185-90
pubmed: 25170357
Semin Arthritis Rheum. 2016 Dec;46(3):319-329
pubmed: 27916278
JAMA. 2016 Oct 11;316(14):1464-1474
pubmed: 27727382
Pain Manag. 2016 May;6(4):383-400
pubmed: 27306300
Rheumatol Int. 2017 Sep;37(9):1527-1539
pubmed: 28447207
JAMA Intern Med. 2013 Mar 11;173(5):355-61
pubmed: 23381623
J Rheumatol. 2011 Oct;38(10):2238-46
pubmed: 21765102
Am J Clin Nutr. 2007 Jan;85(1):277S-279S
pubmed: 17209209
Biomedicines. 2020 Jul 17;8(7):
pubmed: 32709082
Ann Med. 2019;51(sup1):2-14
pubmed: 30735059
PLoS One. 2018 Jan 19;13(1):e0191424
pubmed: 29351568
Curr Rheumatol Rep. 2001 Apr;3(2):128-34
pubmed: 11286669
Pain Res Treat. 2012;2012:426130
pubmed: 23213512
Public Health Nutr. 2017 Aug;20(12):2173-2182
pubmed: 28629485
Appetite. 2017 Jul 1;114:161-168
pubmed: 28359781
Dev Rev. 2013 Dec;33(4):357-370
pubmed: 25580049
Nutr J. 2015 Jul 02;14:66
pubmed: 26134111
Mayo Clin Proc. 2015 May;90(5):680-92
pubmed: 25939940
J Am Coll Nutr. 2014;33(2):176-82
pubmed: 24724775
J Clin Rheumatol. 2006 Jun;12(3):124-8
pubmed: 16755239
Rheumatol Int. 2012 Sep;32(9):2615-21
pubmed: 21833524
Nutrients. 2016 Jun 04;8(6):
pubmed: 27271665
CMAJ. 2003 Jul 8;169(1):47-8
pubmed: 12847042
J Pers Soc Psychol. 1999 Dec;77(6):1121-34
pubmed: 10626367
Saudi J Anaesth. 2019 Apr;13(Suppl 1):S31-S34
pubmed: 30930717
Nutrients. 2020 Aug 20;12(9):
pubmed: 32825400
J Med Internet Res. 2021 Apr 21;23(4):e25228
pubmed: 33658173
Nutrients. 2020 Aug 31;12(9):
pubmed: 32878326
Clin Exp Rheumatol. 2015 Jan-Feb;33(1 Suppl 88):S3-6
pubmed: 25786039